Consensus Phreesia, Inc.

Equities

PHR

US71944F1066

Market Closed - Nyse 04:00:02 2024-04-25 pm EDT 5-day change 1st Jan Change
20.46 USD -6.75% Intraday chart for Phreesia, Inc. -9.55% -11.62%

Evolution of the average Target Price on Phreesia, Inc.

Price target over the last 5 years

History of analyst recommendation changes

7a6ffadf.R0GtdnTINeaIh0nh7Uxq_2qTcclzypg7tc-YKrjnB5U.LADyGRCJBo7MyDmEvB0uhj_QM_wjqNNi4LfCaMjWNMYIMu4gAIYMi-rJeQ~61f0682d7782d39686561a53edb6f0c3
Phreesia Insider Sold Shares Worth $610,684, According to a Recent SEC Filing MT
JMP Securities Raises Price Target on Phreesia to $30 From $28, Maintains Market Outperform Rating MT
Baird Adjusts Price Target on Phreesia to $31 From $30, Maintains Outperform Rating MT
Raymond James Raises Phreesia's Price Target to $30 From $25, Maintains Outperform Rating MT
Canaccord Genuity Adjusts Price Target on Phreesia to $37 From $36, Maintains Buy Rating MT
RBC Raises Price Target on Phreesia to $23 From $17, Cites 'Encouraging Progress Toward Profitability,' Keeps Sector Perform Rating MT
Truist Securities Initiates Phreesia at Buy Rating With $35 Price Target MT
Barclays Starts Phreesia With Overweight Rating, $29 Price Target MT
KeyBanc Adjusts Phreesia's PT to $30 From $40, Maintains Overweight Rating MT
Raymond James Adjusts Price Target on Phreesia to $25 From $30, Keeps Outperform Rating MT
Needham Cuts Price Target on Phreesia to $29 From $40, Maintains Buy Rating MT
RBC Cuts Price Target on Phreesia to $17 From $29 Amid Lower Fiscal 2025 Revenue Outlook, Peer Multiple Compression, Keeps Sector Perform Rating MT
Piper Sandler Cuts Phreesia's Price Target to $40 From $43, Keeps Overweight Rating MT
Raymond James Adjusts Price Target on Phreesia to $30 From $40, Keeps Outperform Rating MT
Canaccord Genuity Adjusts Phreesia's Price Target to $43 From $46, Keeps Buy Rating MT
Citigroup Adjusts Phreesia's Price Target to $37 From $40, Keeps Buy Rating MT
RBC Cuts Price Target on Phreesia to $29 From $33, Highlights Better-than-expected FQ2 EBITDA, Keeps Sector Perform Rating MT
Baird Trims Price Target on Phreesia to $40 From $41, Keeps Outperform Rating MT
Keybanc Adjusts Price Target on Phreesia to $40 From $45, Maintains Overweight Rating MT
Stephens Initiates Phreesia at Overweight With $37 Price Target MT
Guggenheim Adjusts Price Target on Phreesia to $40 From $35, Maintains Buy Rating MT
Jefferies Adjusts Phreesia Price Target to $40 From $47, Maintains Buy Rating MT
DA Davidson Adjusts Price Target on Phreesia to $30 From $28, Maintains Neutral Rating MT
RBC Boosts Price Target on Phreesia to $33 From $26 After Fiscal Q4 Beat, Maintains Sector Perform Rating MT
JMP Securities Adjusts Price Target on Phreesia to $39 From $34, Keeps Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
20.46 USD
Average target price
30.12 USD
Spread / Average Target
+47.24%
High Price Target
37 USD
Spread / Highest target
+80.84%
Low Price Target
23 USD
Spread / Lowest Target
+12.41%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Phreesia, Inc.

JMP Securities
Baird
Raymond James
Canaccord Genuity
RBC Capital Markets
Truist Securities
Barclays
KeyBanc Capital Markets
Needham & Co.
Piper Sandler
Citigroup
Stephens Inc.
Guggenheim
Jefferies & Co.
DA Davidson
SVB Securities LLC
JPMorgan Chase
SVB Leerink
Berenberg Bank
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
  1. Stock Market
  2. Equities
  3. PHR Stock
  4. Consensus Phreesia, Inc.